Article info

other Versions

Download PDFPDF
Treatment patterns after poly-ADP ribose polymerase (PARP) inhibitors in epithelial ovarian cancer patients

Authors

  • Tharani Sivakumaran Peter MacCallum Cancer Centre and Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia PubMed articlesGoogle scholar articles
  • Michael Krasovitsky Department of Medical Oncology, Prince of Wales Hospital and Royal Hospital for Women, Randwick, New South Wales, AustraliaUniversity of New South Wales Prince of Wales Clinical School, Randwick, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Alison Freimund Peter MacCallum Cancer Centre and Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia PubMed articlesGoogle scholar articles
  • Yeh Chen Lee Department of Medical Oncology, Prince of Wales Hospital and Royal Hospital for Women, Randwick, New South Wales, AustraliaUniversity of New South Wales Prince of Wales Clinical School, Randwick, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Kate Webber Department of Medical Oncology, Monash Health, Clayton, Victoria, AustraliaSchool of Clinical Sciences, Monash University, Clayton, Victoria, Australia PubMed articlesGoogle scholar articles
  • Jane So Department of Medical Oncology, Monash Health, Clayton, Victoria, Australia PubMed articlesGoogle scholar articles
  • Christie Norris Department of Medical Oncology, Prince of Wales Hospital and Royal Hospital for Women, Randwick, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Michael Friedlander Department of Medical Oncology, Prince of Wales Hospital and Royal Hospital for Women, Randwick, New South Wales, AustraliaUniversity of New South Wales Prince of Wales Clinical School, Randwick, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Linda Mileshkin Peter MacCallum Cancer Centre and Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, AustraliaDepartment of Gynaecological Oncology, Mercy Hospital for Women, Heidelberg, Victoria, Australia PubMed articlesGoogle scholar articles
  • George Au-Yeung Peter MacCallum Cancer Centre and Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, AustraliaOncology and Dysplasia, The Royal Women's Hospital, Parkville, Victoria, Australia PubMed articlesGoogle scholar articles
  1. Correspondence to Dr George Au-Yeung, Peter MacCallum Cancer Centre and Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia; George.Au-Yeung{at}petermac.org
View Full Text

Citation

Sivakumaran T, Krasovitsky M, Freimund A, et al
Treatment patterns after poly-ADP ribose polymerase (PARP) inhibitors in epithelial ovarian cancer patients

Publication history

  • Received August 9, 2021
  • Accepted March 2, 2022
  • First published March 23, 2022.

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.